Heavy bleeding after giving birth is globally a leading cause of death in new mothers
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the USFDA for an EV therapeutic
The launch is yet another first of its kind innovation in India
An intuitive monitor featuring a patient-tailored approach is now in clinical use in select centres in U.S. and Europe
The hospital is committed to adding to specialised practices in the healthcare space with its pioneering effort to promote oral health awareness and tobacco addiction prevention
Immunocin, an Immuno-modulator drug, significantly reduced the risk of death in the Phase 3 clinical trial in adult patients with moderate-to-severe Covid-19
The companies are now preparing to initiate a Phase 1 trial to assess the safety and immunogenicity of BLB-201 in healthy volunteers
A staggering 65% of the TB cases in India are in the 15-45 age group
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
According to the Indian Council of Medical Research (ICMR), there will be an estimated 12 % rise in cancer cases in India in the next five years
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
